FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Taro Pharmaceuticals U.S.A. Fluorouracil Topical Cream Recall

Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class II
Reported by FDA
Dec 12, 2012
Recall ID
D-086-2013
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Fluorouracil Topical Cream starting Nov 21, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-086-2013 on Dec 12, 2012. Reason: Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples. Status: Terminated.

Why it was recalled

Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.

Product description

Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.

Lot numbers, UPCs & expiration codes

Lot #s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014.

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-086-2013
Classification
Class II
Status
Terminated
Recall initiated
Nov 21, 2012
FDA report date
Dec 12, 2012
Quantity
39,982 Tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-086-2013, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
63685
Address
3 Skyline Dr
Code information
Lot #s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014.
Postal code
10532-2174
Report date
Dec 12, 2012
Product type
Drugs
Recall number
D-086-2013
Classification
Class II
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
39,982 Tubes
Termination date
Apr 11, 2017
Reason for recall
Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Nov 21, 2012
Initial firm notification
Letter
Center classification date
Dec 4, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-086-2013, published Dec 12, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls